Streetwise Reports: The Gold Report, The Energy Report, The Life Sciences Report and Streetwise Reports
755 Baywood Dr, Second Floor
Petaluma, CA 94954
(707) 981-8999 ext: 327
Streetwise Reports: The Gold Report, The Energy Report, The Life Sciences Report and Streetwise Reports are free publications of Streetwise Reports. If you would like to subscribe, please complete our online form.
Interested in becoming a sponsor or an Advertiser?
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
|"INO's revenues and R&D were slightly above our projections."|
|"I wanted to send out a quick update on DXD after two tremendous announcements last week that I believe the market totally missed, which is where we see a major buying opportunity."|
|"DRRX provided a 4Q16 earnings update and indicated that they are actively working towards commencing a Phase 2 trial with an oral formulation of DUR-928 for PSC."|
|"INO's VGX-3100 study should start in 1H17, multiple catalysts ahead in other programs."|
|"RP has successfully completed its first-in-human clinical study of the company's autologous cell therapy for the treatment of androgenetic alopecia."|